233 results
Page 11 of 12
8-K
EX-10.2
iygjzic559x1r8r0y
29 Dec 14
Conkwest Announces $50M In Strategic Investments and Appoints Nantworks Founder, DR. Patrick Soon-shiong As Co-chairman of the Board
12:00am
8-K
EX-4.1
b1bcb6l
23 Dec 14
Entry into a Material Definitive Agreement
12:00am
8-K
zbvdzbzh5f
19 Dec 14
Sorrento and Conkwest Announce Exclusive Global Collaboration
12:00am
8-K
EX-10.1
d2292mqw
19 Dec 14
Sorrento and Conkwest Announce Exclusive Global Collaboration
12:00am
8-K
EX-99.1
lv0x6ruqg dzac
15 Dec 14
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
757d6wbotry2 3k8r
6 Oct 14
Sorrento and Lee’s Pharmaceutical Enter into Exclusive China Licensing Agreement to Develop and CommercializeAnti-PD-L1 antibody
12:00am
8-K
EX-99.1
ruu8t
25 Jun 14
Morphotek and Sorrento Therapeutics Sign an Exclusive Research and Option Agreement to generate and develop Morphotek Antibody Drug Conjugates
12:00am
424B5
gmcnbib
28 Oct 13
Prospectus supplement for primary offering
12:00am
424B5
5rjbmzmf6o
23 Oct 13
Prospectus supplement for primary offering
12:00am
424B5
0z4yatsffjo
7 Oct 13
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
o5hhnqcrwoy1g2zjpwm9
11 Sep 13
Sorrento Therapeutics Completes IgDraSol Merger
12:00am
8-K
EX-2.1
mi63jlw7
11 Sep 13
Sorrento Therapeutics Completes IgDraSol Merger
12:00am
S-3/A
EX-5.1
j3kd61ou8
17 Jul 13
Shelf registration (amended)
12:00am
10-Q/A
EX-10.03
ahz3 r47p
12 Jul 13
Quarterly report (amended)
12:00am
10-Q/A
EX-2.1
w4p8w32tgf01l
12 Jul 13
Quarterly report (amended)
12:00am